E50 Pill - pink capsule/oblong, 23mm
Pill with imprint E50 is Pink, Capsule/Oblong and has been identified as Etoposide 50 mg. It is supplied by Mylan Pharmaceuticals Inc.
Etoposide is used in the treatment of Small Cell Lung Cancer; Hodgkin's Lymphoma; Ovarian Cancer; Testicular Cancer; Cancer and belongs to the drug class mitotic inhibitors. There is positive evidence of human fetal risk during pregnancy. Etoposide 50 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for E50
Etoposide
- Imprint
- E50
- Strength
- 50 mg
- Color
- Pink
- Size
- 23.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Mitotic inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC)
- 00378-3266
- Inactive Ingredients
-
citric acid anhydrous,
glycerin,
polyethylene glycol,
gelatin,
ferric oxide red,
titanium dioxide,
FD&C Blue No. 1,
FD&C Red No. 40,
hypromelloses,
propylene glycol
Note: Inactive ingredients may vary.
Related images for "E50"
More about etoposide
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: mitotic inhibitors
- Breastfeeding
Patient resources
- Etoposide drug information
- Etoposide injection
- Etoposide phosphate
- Etoposide (Intravenous) (Advanced Reading)
- Etoposide (Oral) (Advanced Reading)
- Etoposide Capsules
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
